Skip to main content
letter
. 2017 Nov 30;118(1):32–37. doi: 10.1038/bjc.2017.394

Table 2. CSF mutational and therapeutic results.

Patient CSF-sensitive mutation CSF T790M PS Neurological FindingsChange CNS radiographic change Extra-CNS rebiopsy site/T790M status Extra-CNS response
1 L858R + 3→1 Abnormal→Improved Improved Bone/+ PR
2 Del-19 + 3→1 Abnormal→Improved Improved Lung/+ NE
3 Del-19 3→3 Abnormal→Stable Stable Liver/+ PR
4 Del-19 2→2 Abnormal→Stable Stable Lymph node/+ NE
5 L858R 3→4 Abnormal→Worsened Progressed Lung/+ SD
6 1→1 Normal →Stable Improved Pleura/+ PR
7 2→1 Normal →Stable Stable Pleura/+ SD
8 1→1 Normal →Stable Improved Lung/+ PR
9 1→1 Normal →Stable Improved Lung/+ PR
10 1→1 Abnormal→Improved Improved Lung/+ PR
11 3→1 Abnormal→Improved Improved Liver/+ SD
12 1→1 Normal →Stable Improved Pleura/+ PR
13 1→1 Normal →Stable NE Lung/+ PR

Abbreviations: CNS=central nervous system; CSF=cerebrospinal fluid; NE=not evaluable; PR=partial response; PS=performance status; Pt=patient; SD=stable disease.